(Q83279490)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19186203%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

title

Long-term efficacy of plasma-derived and recombinant hepatitis B vaccines in a rural township of Central Taiwan (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19186203%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

Jung-Ta Kao

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19186203%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Jing-Houng Wang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19186203%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Chao-Hung Hung

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19186203%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Yi-Hao Yen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19186203%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Shu-Fen Hung

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19186203%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Tsung-Hui Hu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19186203%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Chuan-Mo Lee

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19186203%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Sheng-Nan Lu

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19186203%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

publication date

30 January 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19186203%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

number of pages

5

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19186203%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19186203%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19186203%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

1858-1862

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19186203%20AND%20SRC:MED&resulttype=core&format=json

A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers

20 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.027

Long-term persistence of immunity to hepatitis B after vaccination during infancy in a country where endemicity is low.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.027

Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.027

Geographic and ethnic variations of long-term efficacy and immunogenicity of hepatitis B vaccination in Hualien, a HBV hyperendemic area

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.027

Seroepidemiologic survey for hepatitis B virus infection in Taiwan: the effect of hepatitis B mass immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.027

Long-term persistence of anti-HBs after vaccination against HBV: an 18 year experience in health care workers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.027

Persistence of immunologic memory for 13 years in recipients of a recombinant hepatitis B vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.027

Viremia profiles in children with chronic hepatitis B virus infection and spontaneous e antigen seroconversion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.027

Twelve-year follow-up of a prospective randomized trial of hepatitis b recombinant DNA yeast vaccine versus plasma-derived vaccine without booster doses in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.027

Study of hepatitis B (HB) vaccine non-responsiveness among health care workers from an endemic area (Taiwan).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.027

Seroepidemiology of hepatitis B virus infection in children: Ten years of mass vaccination in Taiwan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.027

Serological pattern ?anti-HBc alone?: Report on a workshop

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.027

Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.027

Changing aetiology of liver dysfunction in the new generation of a hepatitis B and C-endemic area: cross-sectional studies on adolescents born in the first 10 years after universal hepatitis B vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.027

Hepatitis B virus infection in adolescents in a rural township--15 years subsequent to mass hepatitis B vaccination in Taiwan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.027

Long-term immunogenicity of hepatitis B vaccination in a cohort of Italian healthy adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.027

Long-term efficacy of recombinant hepatitis B vaccine and risk of natural infection in infants born to mothers with hepatitis B e antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.027

Lifelong protection against hepatitis B: the role of vaccine immunogenicity in immune memory

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.027

Clinical evaluation of a recombinant hepatitis B vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.027

Long term immunogenicity safety and efficacy of a recombinant hepatitis B vaccine in healthy adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.027

Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.027

Seroepidemiology of hepatitis B virus infection and high rate of response to hepatitis B virus Butang vaccine in adolescents from low income families in Central Brazil.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.027

Female children respond to recombinant hepatitis B vaccine with a higher titre than male

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.027

10.1016/J.VACCINE.2009.01.027

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19186203%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference